Cargando…
_version_ 1784780027885256704
author Tavernari, L.
Rontauroli, S.
Maccaferri, M.
Mora, B.
Bianchi, E.
Parenti, S.
Genovese, E.
Guglielmelli, P.
Carretta, C.
Mallia, S.
Mirabile, M.
Sartini, S.
Colasante, C.
Potenza, L.
Passamonti, F.
Tagliafico, E.
Luppi, M.
Vannucchi, A. M.
Manfredini, R.
author_facet Tavernari, L.
Rontauroli, S.
Maccaferri, M.
Mora, B.
Bianchi, E.
Parenti, S.
Genovese, E.
Guglielmelli, P.
Carretta, C.
Mallia, S.
Mirabile, M.
Sartini, S.
Colasante, C.
Potenza, L.
Passamonti, F.
Tagliafico, E.
Luppi, M.
Vannucchi, A. M.
Manfredini, R.
author_sort Tavernari, L.
collection PubMed
description
format Online
Article
Text
id pubmed-9431340
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94313402022-08-31 P1003: PERIPHERAL BLOOD CYTOTOXIC T CELLS SHOW EARLY EXHAUSTED FEATURES IN MYELOFIBROSIS PATIENTS Tavernari, L. Rontauroli, S. Maccaferri, M. Mora, B. Bianchi, E. Parenti, S. Genovese, E. Guglielmelli, P. Carretta, C. Mallia, S. Mirabile, M. Sartini, S. Colasante, C. Potenza, L. Passamonti, F. Tagliafico, E. Luppi, M. Vannucchi, A. M. Manfredini, R. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431340/ http://dx.doi.org/10.1097/01.HS9.0000846880.96285.fa Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Tavernari, L.
Rontauroli, S.
Maccaferri, M.
Mora, B.
Bianchi, E.
Parenti, S.
Genovese, E.
Guglielmelli, P.
Carretta, C.
Mallia, S.
Mirabile, M.
Sartini, S.
Colasante, C.
Potenza, L.
Passamonti, F.
Tagliafico, E.
Luppi, M.
Vannucchi, A. M.
Manfredini, R.
P1003: PERIPHERAL BLOOD CYTOTOXIC T CELLS SHOW EARLY EXHAUSTED FEATURES IN MYELOFIBROSIS PATIENTS
title P1003: PERIPHERAL BLOOD CYTOTOXIC T CELLS SHOW EARLY EXHAUSTED FEATURES IN MYELOFIBROSIS PATIENTS
title_full P1003: PERIPHERAL BLOOD CYTOTOXIC T CELLS SHOW EARLY EXHAUSTED FEATURES IN MYELOFIBROSIS PATIENTS
title_fullStr P1003: PERIPHERAL BLOOD CYTOTOXIC T CELLS SHOW EARLY EXHAUSTED FEATURES IN MYELOFIBROSIS PATIENTS
title_full_unstemmed P1003: PERIPHERAL BLOOD CYTOTOXIC T CELLS SHOW EARLY EXHAUSTED FEATURES IN MYELOFIBROSIS PATIENTS
title_short P1003: PERIPHERAL BLOOD CYTOTOXIC T CELLS SHOW EARLY EXHAUSTED FEATURES IN MYELOFIBROSIS PATIENTS
title_sort p1003: peripheral blood cytotoxic t cells show early exhausted features in myelofibrosis patients
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431340/
http://dx.doi.org/10.1097/01.HS9.0000846880.96285.fa
work_keys_str_mv AT tavernaril p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT rontaurolis p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT maccaferrim p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT morab p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT bianchie p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT parentis p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT genovesee p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT guglielmellip p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT carrettac p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT mallias p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT mirabilem p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT sartinis p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT colasantec p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT potenzal p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT passamontif p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT tagliaficoe p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT luppim p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT vannucchiam p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients
AT manfredinir p1003peripheralbloodcytotoxictcellsshowearlyexhaustedfeaturesinmyelofibrosispatients